Thalidomide and Hydroxyurea Combination in β-Thalassemia Patients
Clinical trial NCT06153784 · COMPLETED
Trial details
- NCT number
- NCT06153784
- Sponsor
- Children's Hospital Karachi
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-07
- Primary completion
- 2023-07-30
- Enrollment
- 603
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.